Preparation and applications of biocompatible conductive inks based on cellulose nanofibrils for 3D printing of conductive biomedical devices and for use as models for study of neurodegenerative disorders and connection between brain/neurons and communication or other electronic devices
The present invention relates to preparation and use of nanocellulose fibrils or crystals such as disintegrated bacterial nanocellulose, tunicate-derived nanocellulose, or plant-derived nanocellulose, together with carbon nanotubes, as a biocompatible and conductive ink for 3D printing of electrically conductive patterns. Biocompatible conductive bioinks described in this invention were printed in the form of connected lines onto wet or dried nanocellulose films, bacterial cellulose membrane, or tunicate decellularized tissue. The devices were biocompatible and showed excellent mechanical properties and good electrical conductivity through printed lines (3.8·10 −1 S cm −1 ). Such scaffolds were used to culture neural cells. Neural cells attached selectively on the printed pattern and formed connective networks. The devices prepared by this invention are suited as bioassays to screen drugs against neurodegenerative diseases such as Alzheimer's and Parkinson's, study brain function, and/or be used to link the human brain with electronic and/or communication devices. They can also be implanted to replace neural tissue or stimulate guiding of neural cells. They can also be used to stimulate the heart by using electrical signaling or to repair myocardial infarction and/or damage related thereto.
1. A biocompatible and electrically conductive three-dimensional printing ink comprising nanocellulose dispersed in water, the nanocellulose comprising hydrolyzed or disintegrated bacterial cellulose, nanocellulose fibrils, nanocellulose nanocrystals, disintegrated bacterial cellulose, nanocellulose isolated from tunicates, and/or nanocellulose isolated from plants, with or without the addition of carbon nanotubes, capable of forming three-dimensional electrically conductive patterns.
2. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the biocompatible and electrically conductive three-dimensional printing ink comprising nanocellulose dispersed in water is used to three-dimensional print the electrically conductive patterns onto biocompatible nanocellulose three-dimensional substrate support(s), wherein the resulting product is biocompatible and electrically conductive.
3. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the three-dimensional electrically conductive patterns are used for culturing neural cells to form neural networks.
4. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the three-dimensional electrically conductive patterns are used for drug discovery or testing treatments or to be used as a neurodegenerative disease model.
5. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the three-dimensional electrically conductive patterns are used for culturing induced pluripotent stem cells, mesenchymal stem cells, neuroprogenitor cells, and/or neural cells, to form neural networks.
6. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the three-dimensional electrically conductive patterns are used for culturing neural cells to form neural networks and is used to link the brain or neurons with an electronic or communication device, chosen from one or more of the following: a phone, a cellular phone, a computer processing unit, a computer, a display screen, and/or a wireless device.
7. The biocompatible and electrically conductive three-dimensional printing ink of claim 3 , wherein living neural tissue is used for culturing neural cells to form neural networks.
8. The biocompatible and electrically conductive three-dimensional printing ink of claim 3 , wherein living neural tissue is used for culturing neural cells to form neural networks, which are implanted in a human or animal.
9. The biocompatible and electrically conductive three-dimensional printing ink of claim 5 , wherein living neural tissue is used to form the neural network, which is implanted in a human or animal.
10. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the three-dimensional electrically conductive patterns are capable of treating animals and/or humans suffering from a tissue defect by implanting the three-dimensional electrically conductive patterns in or on the animals and/or humans suffering from the tissue defect.
11. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the three-dimensional electrically conductive patterns are capable of treating animals and/or humans by replacing brain, heart, and/or neural tissue, and/or by implanting in or around brain, heart, and/or neural tissue.
12. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the three-dimensional electrically conductive patterns are capable of treating animal and/or human organs by providing electrical impulses to the three-dimensional electrically conductive patterns.
13. The biocompatible and electrically conductive three-dimensional printing ink of claim 1 , wherein the three-dimensional electrically conductive patterns are capable of treating animal and/or human organs by implanting the three-dimensional electrically conductive patterns into or onto the heart and/or heart tissue and stimulating heart cells to grow and repair and/or treat myocardial infarction, damage caused by myocardial infarction, and/or other heart pathology.
14. The biocompatible and electrically conductive three-dimensional printing ink of claim 2 , wherein the biocompatible nanocellulose three-dimensional substrate support(s) are used as a wet membrane or are printed and dried.
15. The biocompatible and electrically conductive three-dimensional printing ink of claim 2 , wherein the biocompatible nanocellulose three-dimensional substrate support(s) comprise bacterial nanocellulose, tunicate-derived nanocellulose, and/or plant-derived nanocellulose.
16. The biocompatible and electrically conductive three-dimensional printing ink of claim 12 , wherein the animal and/or human organs comprise a heart, a brain, or both.
17. The biocompatible and electrically conductive three-dimensional printing ink of claim 13 , wherein the animal and/or human organs comprise a heart.